NEO NeoGenomics, Inc.
$17.93▼ -0.33%
Healthcare
Other
After hours
$17.91▼ -0.11%
Oct 29, 4:00 PM ET
Volume 3.76M
Avg Volume (10D) 1.81M
Key Metrics & Fundamentals
Market Cap
$2.30B
P/E Ratio
–
Div Yield
0.00%
52W Range
7.07 - 20.15
% vs 50 MA
1.49%
% vs 200 MA
40.50%
RSI-14
56.0
MACD Histogram
+0.1500
Beta (1Y vs SPY)
1.04
Free Cash Flow
$11.74M
Gross Rev
$201.66M
Gross Profit
$91.88M
EBITDA
$7.64M
COGS
$109.78M
Operating Exp
$101.65M
Operating Income
-$9.77M
EBIT
-$9.77M
Pretax Income
$1.83M
Net Income
$2.24M
EPS (Diluted)
0.02
Price & Volume History
Loading chart…
Recent News
NeoGenomics (NEO) Beat Q3 Expectations, Is The Stock Still Cheap?
Simply Wall St. · Oct 29, 2026 1:10 PM ET
NeoGenomics Inc (NEO) Q3 2026 Earnings Call Highlights: Revenue Tops $209 Million as NGS Surges ...
GuruFocus.com · Oct 29, 2026 9:07 AM ET
What NeoGenomics (NEO) Said on Its Q3 Earnings Call
MarketBeat · Oct 29, 2026 1:04 AM ET
NeoGenomics (NEO) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 29, 2026 12:13 AM ET
NeoGenomics (NEO) Q3 Earnings and Revenues Beat Estimates
Zacks · Oct 28, 2026 6:30 PM ET
NeoGenomics: Q3 Earnings Snapshot
Associated Press · Oct 28, 2026 4:59 PM ET
NeoGenomics’s (NASDAQ:NEO) Q3 2026 sales beat estimates
StockStory · Oct 28, 2026 4:26 PM ET
NeoGenomics Reports Third Quarter 2026 Results
Business Wire · Oct 28, 2026 4:05 PM ET
Earnings to watch: NeoGenomics (NEO) reports Q3 results tomorrow
StockStory · Oct 27, 2026 11:50 AM ET
IBD Stock Of The Day, Natera, Hovering Near Buy Point
Investor's Business Daily · Oct 22, 2026 5:40 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NEO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.